Growth Hormone Therapy in Liver Cirrhosis
Growth Hormone Therapy and Its Effect on Nitrogen Metabolism and Malnutrition in Liver Cirrhosis
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
This PHASE2/PHASE3 trial investigates Cirrhosis, Liver and is currently completed. Post Graduate Institute of Medical Education and Research, Chandigarh leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2023 — Apr 2024 [monthly]
Completed PHASE2_PHASE3
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Jan 2021 — Jun 2023 [monthly]
Unknown Status PHASE2_PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .